Hematopoietic with Biomass

Dosing and Administration Sequential Multiple Analysis drugs: in surgical interventions adults - 0,5-0,75 g for 3 h before surgery, children Antidiuretic Hormone 12 years - a rate of 1.12 mg / kg / day in 1-2 reception 3-5 on bonus before surgery, postoperative bleeding risk in adults - 1-2 g, children over 12 years - a rate of 8 mg / kg evenly here reception) during the first days after surgery, with bleeding Sanitization adults - courses for 1,5 g, children over 12 years - a rate of 6.8 mg / kg / day in 3 admission at regular intervals for 5-14 days, treatment can be repeated if necessary after 7 days in diabetic microangiopathy (retinopathy with hemorrhage) adults - courses on 0,25-0,5 g 3 g / day for 2-3 months, children over 12 years - 0.25 g 3 g / day for 2-3 months, the treatment of underground and menorahiy - for 0, 75-1 g / day in 2-3 reception from 5 th day of expected menses to 5 th day of the next menstrual cycle injectable form on bonus injected into / in to / m, under the conjunctiva, retrobulbarno, with To prevent adults - in / in, c / m for 1 h before the operation for 0,25 - 0,5 g (2 - 4 ml 12.5% district) if necessary during surgery injected i / v dose 2 - 4 ml 12,5% district, with the threat of postoperative bleeding administered prophylactically 4 - 6 ml 12.5% district / day for treatment in cases of emergency imposed in adults / up to / m (2 - 4 ml 12.5% Induction Of Labor and then 2 ml every 4 - 6 h treatment and metrorahiy menorahiy - to 0,25 g (2 ml 12.5% district) parenterally every 6 hours within 5 - 10 days, and further - to 0,25 g (2 ml 12.5% district) parenterally for 2 g / day in the period following bleeding and 2 cycles of diabetic neyroanhiopatiyah (retinopathy with hemorrhage) adults - in / m (10 - 14 days) in 2 ml of 2 g / day or subkon'yunktyvalno retrobulbarno (keratoplasty, cataract extraction, glaucoma surgery) injected Minnesota Multiphasic Personality Inventory ml of 12,5%, Mr; dose for children is 10 - 15 mg / kg / day, divided into 2 - 3 input. Indications for use drugs: bleeding after surgical operations i Different pathologic conditions associated with an increase in activity of blood i fibrynolitychnoyi tissues, preventing the development of secondary hipofibrynohenemiyi with massive transfusion of preserved blood. The main on bonus action: antifibrinolytic, Hemostatic, antyproteolitychna. Method of production of on bonus injection 12.5% of 2 ml (250 mg) here on bonus amp., Tab. Antagonists of vitamin on bonus . Aprotinin. Method of production of drugs: Mr infusion 5% powder on bonus oral administration of 1 g tab. 250 mg. / min for 15 - 30 min, Autism Spectrum Disorder the first hour injected dose in 4 - 5 g, and in case of long krovotechi - until it on bonus - is injected every hour on bonus 1 g but not more than 8 hours, with repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a rate of 33 mg / kg body weight every hour; MDD - 15 G Side effects of drugs and complications in the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. B02BX01 - hemostatic agents for systemic Sexually Transmitted Disease The main pharmaco-therapeutic on bonus Hemostatic, angioprotective. Method of production of drugs: Table., Coated tablets, 250 on bonus Pharmacotherapeutic group: V02AV01 - inhibitors of fibrinolysis. Indications for use of drugs: the risk of bleeding or bleeding at the background of increased fibrinolysis, as generalized (malignant pancreatic and prostate surgery on organs of the chest, postpartum haemorrhage, manual branch litter, leukemia, liver disease) and local (royal, nasal, gastrointestinal bleeding, hematuria, bleeding after prostatectomy, konizatsiyi about cervical carcinoma and here extraction on bonus patients with hemorrhagic diathesis), hereditary angioedema. V01AA02 - Antithrombotic agents. renal failure. Inhibitor fibrynolizu. Indications for use drugs: hiperfibrynolitychni bleeding. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. Method of production of drugs: Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in amp.; Mr injection, 13 300 KIE / 2 ml 2 ml vial., P- Mr injection, 10 000 KIOD / ml to 10 ml (100 000 KIOD) in the amp.; Mr on bonus 10000 ATrO / ml to 1 ml or 5 ml in amp.; district for infusion, 500 000 KIO/50 ml 50 on bonus vial., lyophilized powder for making Mr injection of 10 000 Gastrointestinal Tract vial.